The week · fixed on Sunday evening

2–8 November 2026

1805 stories from 389 outlets in 56 countries; 56 were covered by more than one outlet. Daily editions: 02, 03, 04, 05, 06, 07, 08.

Most covered

FDA Press Announcements 7 outlets · 2026-11-08

FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherap

Explainers that changed · new, re-rated or updated this week

Alcohol new explainer · evidence 9/10, thoroughly established

Alcohol is the most widely used drug, and the evidence on its health effects has hardened over the past decade: the old idea that moderate drinking protects the heart has largely collapsed under better-designed studies, and even low intake raises the risk of …

Estrogen new explainer · evidence 9/10, thoroughly established

Estrogen is the main female sex hormone, produced mostly by the ovaries until menopause, with roles in bone, heart, brain and skin as well as reproduction. Its medical uses are hormone therapy for menopause symptoms, contraception and gender-affirming care; i…

Stem cell therapy new explainer · evidence 6/10, mixed or limited trials

Stem cell therapy uses cells that can renew themselves and become other cell types to repair or replace tissue. Proven uses are narrow: bone marrow and blood stem cell transplants for leukaemia, lymphoma and some blood disorders, plus a few approved products …

Happiness new explainer

Happiness research sits where psychology, economics and public health meet: how life satisfaction and day-to-day mood relate to income, relationships, work, health and age, and whether they can be changed. Robust findings include the strength of social connec…

Cancer new explainer

Cancer is not one disease but several hundred, grouped by the tissue where abnormal cells start dividing without control. Coverage on Alivewire spans the whole field: screening programmes and their false alarms, new targeted and immune therapies, survivorship…

Obesity new explainer

Obesity is defined clinically by body-mass index, a crude measure that researchers increasingly want to replace with body composition and metabolic health. It raises the risk of diabetes, heart disease, several cancers and joint disease, and it is now treated…

Alzheimer's disease new explainer

Alzheimer's disease is the most common cause of dementia, marked by amyloid plaques and tau tangles in the brain and a slow loss of memory and function over years. Two antibody drugs that clear amyloid are approved in some countries but slow decline only mode…

ADHD new explainer

ADHD, attention-deficit hyperactivity disorder, is a neurodevelopmental condition of inattention, impulsivity and restlessness that begins in childhood and persists into adulthood in roughly half of cases. Stimulant medications are effective and well studied,…

Lung cancer new explainer

Lung cancer is the leading cause of cancer death worldwide, and about 85 percent of cases are tied to smoking, though rates among never-smokers, especially women in Asia, are rising. Survival has improved with targeted drugs for tumours carrying specific muta…

COVID-19 new explainer

COVID-19 is the disease caused by SARS-CoV-2, now circulating as a seasonal respiratory virus with periodic variant waves. Current research focuses on long COVID, how long vaccine and infection immunity lasts, the virus's lingering effects on the heart and br…

Women's health new explainer

Women's health covers conditions that affect women only, differently, or more often: reproductive and maternal care, menopause, autoimmune disease, migraine, osteoporosis, and the heart disease that is diagnosed later in women than in men. The field's recurri…

Breast cancer new explainer

Breast cancer is the most common cancer in women worldwide and one of the most studied, with survival above 90 percent at five years when found early in high-income countries. Treatment is now sorted by subtype (hormone-receptor, HER2, triple-negative), and t…

Longevity & Aging

Fitness

Medicine & Biotech

Mind & Brain

Nutrition

Products

Pharmacy Times

Public Health

Sleep

Health Tech

Wellness